The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses

Mireille H. Lahoud, Anna I. Proietto, Fatma Ahmet, Susie Kitsoulis, Liv Eidsmo, Li Wu, Priyanka Sathe, Suzanne Pietersz, Hsuen Wen Chang, Ian D. Walker, Eugene Maraskovsky, Hal Braley, Andrew M. Lew, Mark D. Wright, William R. Heath, Ken Shortman, Irina Caminschi

研究成果: 雜誌貢獻文章同行評審

89 引文 斯高帕斯(Scopus)

摘要

We have cloned the mouse and human C-type lectin Clec12A, expressed both, and produced mAb recognizing both. Mouse Clec12A is highly expressed on splenic CD8+ dendritic cells (DC) and plasmacytoid DC. A proportion of CD8-DC also expresses lower levels of Clec12A, as do monocytes, macrophages, and B cells. Human CLEC12A, like the mouse counterpart, is expressed on blood monocytes and DC, including pDC and BDCA-3+DC, the proposed equivalent of mouse CD8+DC. To determine whether Ag targeted to Clec12A could induce immune responses, mice were injected with a rat mAb recognizing Clec12A, or a control rat mAb, then production of anti-rat Ig was measured. Anti-Clec12A mAb alone produced only moderate responses, but these were amplified by coinjecting only small amounts of LPS as a DC activation agent. Furthermore, when OVA was conjugated to anti-Clec12A mAb, OVA-specific T cells were induced to proliferate. This Ag presentation to naive T cells was due to targeting conventional DC, because their ablation eliminated T cell activation. The potent Ab responses induced using microgram amounts of anti-Clec12A and minimal amounts of adjuvant demonstrate that this molecule can be used as an Ag-delivery target to enhance Ab responses to vaccines.
原文英語
頁(從 - 到)7587-7594
頁數8
期刊Journal of Immunology
182
發行號12
DOIs
出版狀態已發佈 - 六月 15 2009
對外發佈

ASJC Scopus subject areas

  • 免疫學

指紋

深入研究「The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses」主題。共同形成了獨特的指紋。

引用此